Published in Proteomics on April 01, 2010
Genetic incorporation of unnatural amino acids into proteins in mammalian cells. Nat Methods (2007) 3.45
Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev (2003) 2.52
Dentin matrix protein 1, a target molecule for Cbfa1 in bone, is a unique bone marker gene. J Bone Miner Res (2002) 2.36
Platinum-gold nanoparticles: a highly active bifunctional electrocatalyst for rechargeable lithium-air batteries. J Am Chem Soc (2010) 2.10
High-power lithium batteries from functionalized carbon-nanotube electrodes. Nat Nanotechnol (2010) 1.69
A genetically encoded fluorescent amino acid. Proc Natl Acad Sci U S A (2006) 1.66
Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics (2007) 1.57
Coherent phonon heat conduction in superlattices. Science (2012) 1.53
microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells. J Ovarian Res (2014) 1.50
Four distinct pathways of hemoglobin uptake in the malaria parasite Plasmodium falciparum. Proc Natl Acad Sci U S A (2008) 1.47
Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial. Circulation (2002) 1.46
Adsorption of ionizable organic contaminants on multi-walled carbon nanotubes with different oxygen contents. J Hazard Mater (2010) 1.45
Protein-protein interactions of tandem affinity purification-tagged protein kinases in rice. Plant J (2006) 1.42
Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol (2007) 1.40
Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib. J Clin Oncol (2007) 1.40
Identification of highly active Fe sites in (Ni,Fe)OOH for electrocatalytic water splitting. J Am Chem Soc (2015) 1.40
The emergence of clinical resistance to tigecycline. Int J Antimicrob Agents (2012) 1.35
Core-protected platinum monolayer shell high-stability electrocatalysts for fuel-cell cathodes. Angew Chem Int Ed Engl (2010) 1.34
An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics (2005) 1.25
Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J Proteome Res (2006) 1.23
Heavy doping and band engineering by potassium to improve the thermoelectric figure of merit in p-type PbTe, PbSe, and PbTe(1-y)Se(y). J Am Chem Soc (2012) 1.23
Using average cost methods to estimate encounter-level costs for medical-surgical stays in the VA. Med Care Res Rev (2003) 1.17
Isolation and characterization of RNA polymerase rpoB mutations that alter transcription slippage during elongation in Escherichia coli. J Biol Chem (2012) 1.10
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen. J Thorac Oncol (2009) 1.10
Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma. J Proteome Res (2008) 1.07
A dataset of human fetal liver proteome identified by subcellular fractionation and multiple protein separation and identification technology. Mol Cell Proteomics (2006) 1.04
A strategy for precise and large scale identification of core fucosylated glycoproteins. Mol Cell Proteomics (2009) 1.03
In vitro bactericidal activity of allicin combined with cefoperazone, tobramycin and ciprofloxacin. Int J Antimicrob Agents (2007) 1.03
Relative recirculation: a fast, model-free surrogate for the measurement of blood-brain barrier permeability and the prediction of hemorrhagic transformation in acute ischemic stroke. Invest Radiol (2009) 1.02
Proteome analysis of hepatocellular carcinoma by laser capture microdissection. Proteomics (2006) 1.02
Mutant prevention concentration-based pharmacokinetic/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureus. Antimicrob Agents Chemother (2011) 1.02
Carbon nanotube/manganese oxide ultrathin film electrodes for electrochemical capacitors. ACS Nano (2010) 1.00
Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis. Hepatology (2010) 0.99
Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy. Proteomics (2008) 0.99
Flow injection analysis of chemical oxygen demand (COD) by using a boron-doped diamond (BDD) electrode. Environ Sci Technol (2009) 0.99
A fast workflow for identification and quantification of proteomes. Mol Cell Proteomics (2013) 0.98
Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes. PLoS One (2013) 0.98
Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma. Tumour Biol (2013) 0.97
Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. Int J Antimicrob Agents (2008) 0.97
Proteomic analysis of individual variation in normal livers of human beings using difference gel electrophoresis. Proteomics (2006) 0.97
Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells. Cancer Invest (2008) 0.96
Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells. Proteomics (2008) 0.96
Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease. Mol Cell Proteomics (2008) 0.96
Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer. J Proteome Res (2010) 0.95
Average cost of VA rehabilitation, mental health, and long-term hospital stays. Med Care Res Rev (2003) 0.95
Applying an electric field in a built-in zero valent iron--anaerobic reactor for enhancement of sludge granulation. Water Res (2010) 0.94
Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project. Proteomics (2005) 0.94
Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics (2003) 0.94
miR-145 and miR-143 regulate odontoblast differentiation through targeting Klf4 and Osx genes in a feedback loop. J Biol Chem (2013) 0.94
Layer-by-layer assembly of all carbon nanotube ultrathin films for electrochemical applications. J Am Chem Soc (2009) 0.94
The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy. Gynecol Oncol (2013) 0.93
PepDistiller: A quality control tool to improve the sensitivity and accuracy of peptide identifications in shotgun proteomics. Proteomics (2012) 0.93
Molecular detection of anaerobic ammonium-oxidizing (anammox) bacteria in high-temperature petroleum reservoirs. Microb Ecol (2010) 0.93
Blocking of proteolytic processing and deletion of glycosaminoglycan side chain of mouse DMP1 by substituting critical amino acid residues. Cells Tissues Organs (2008) 0.93
Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC. Proteomics (2008) 0.93
Transferred subgroup false discovery rate for rare post-translational modifications detected by mass spectrometry. Mol Cell Proteomics (2013) 0.93
Highly stable Pt monolayer on PdAu nanoparticle electrocatalysts for the oxygen reduction reaction. Nat Commun (2012) 0.92
Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome. Proteomics (2010) 0.92
Integrating plasmonic nanoparticles with TiO₂ photonic crystal for enhancement of visible-light-driven photocatalysis. Environ Sci Technol (2012) 0.92
Binding of amelogenin to MMP-9 and their co-expression in developing mouse teeth. J Mol Histol (2012) 0.92
Antibacterial activity of allicin alone and in combination with beta-lactams against Staphylococcus spp. and Pseudomonas aeruginosa. J Antibiot (Tokyo) (2007) 0.92
Solid tumor penetration by integrin-mediated pegylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel. Biomaterials (2012) 0.91
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma. Carcinogenesis (2012) 0.91
Determining functional connectivity using fMRI data with diffusion-based anatomical weighting. Neuroimage (2012) 0.91
Photonic crystal coupled TiO(2)/polymer hybrid for efficient photocatalysis under visible light irradiation. Environ Sci Technol (2010) 0.91
The cardiotoxicity of macrolides: a systematic review. Pharmazie (2010) 0.91
Modified Wiener estimation of diffuse reflectance spectra from RGB values by the synthesis of new colors for tissue measurements. J Biomed Opt (2012) 0.91
Fragmentation and site-specific quantification of core fucosylated glycoprotein by multiple reaction monitoring-mass spectrometry. Anal Chem (2011) 0.90
On the origin of the unique properties of supported Au nanoparticles. J Am Chem Soc (2006) 0.89
Mass spectral profiling: an effective tool for quality control of herbal medicines. Anal Chim Acta (2007) 0.89
Proteomic analysis on structural proteins of Severe Acute Respiratory Syndrome coronavirus. Proteomics (2004) 0.89
Proteomic analysis of human age-related nuclear cataracts and normal lens nuclei. Invest Ophthalmol Vis Sci (2011) 0.89
Bayesian nonparametric model for the validation of peptide identification in shotgun proteomics. Mol Cell Proteomics (2008) 0.89
Two-dimensional blue native/SDS-PAGE analysis reveals heat shock protein chaperone machinery involved in hepatitis B virus production in HepG2.2.15 cells. Mol Cell Proteomics (2008) 0.88
Effects of an electric field and zero valent iron on anaerobic treatment of azo dye wastewater and microbial community structures. Bioresour Technol (2010) 0.88
Distinct radiosensitivity of lung carcinoma stem-like side population and main population cells. Cancer Biother Radiopharm (2013) 0.88
Abnormalities in the enamel in bmp2-deficient mice. Cells Tissues Organs (2011) 0.88
Preparation and characteristics of carbon-supported platinum catalyst and its application in the removal of phenolic pollutants in aqueous solution by microwave-assisted catalytic oxidation. J Hazard Mater (2008) 0.87
Characterization of the liver tissue interstitial fluid (TIF) proteome indicates potential for application in liver disease biomarker discovery. J Proteome Res (2010) 0.87
The role of EMMPRIN expression in ovarian epithelial carcinomas. Cell Cycle (2013) 0.87
Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals. AIDS Patient Care STDS (2012) 0.87
Visible light photoelectrocatalysis with salicylic acid-modified TiO2 nanotube array electrode for p-nitrophenol degradation. J Hazard Mater (2008) 0.86
Analysis of human liver proteome using replicate shotgun strategy. Proteomics (2007) 0.86
Proteomics-based generation and characterization of monoclonal antibodies against human liver mitochondrial proteins. Proteomics (2006) 0.86